Loss of FHIT expression in gastric mucosa of patients with family histories of gastric cancer and Helicobacter pylori infection

World Journal of Gastroenterology

Volumn 11, Issue 1, 2005, Pages 17-21

  Stec Michalska, Krystyna ^a   Antoszczyk, Slawomir ^b   Klupinska, Grazyna ^a   Nawrot, Barbara ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b CENTRE OF MOLECULAR AND MACROMOLECULAR STUDIES   (Poland)

Author keywords

FHIT protein; Gastric cancer; Helicobacter pylori infection

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN; MESSENGER RNA; UREASE;

ADULT; ARTICLE; BACTERIAL COLONIZATION; CANCER PREVENTION; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DYSPEPSIA; EARLY DIAGNOSIS; FAMILY HISTORY; FEMALE; GENE LOSS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEREDITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFECTION SENSITIVITY; MALE; PATIENT MONITORING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; STOMACH ANTRUM; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; STOMACH MUCOSA;

EID: 11844255672     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i1.17     Document Type: Article

References (23)

1. Wronkowski Z, Zwierko M, Chmielarczyk W. Epidemiology of malingant tumors in Poland. Przewodnik lekarza 2000: 12-14
2. Popiela T, Kulig J. Multi-theraphy as a chance for improvement of a treatment of gastric carcinoma in Poland. Nowotwory 1996; 46(Suppl 1): 28-74
3. Baffa R, Veronese ML, Santoro R, Mandes B, Palazzo JP, Rugge M, Santoro E, Croce CM, Huebner K. Loss of FHIT expression in gastric carcinoma. Cancer Res 1998; 58: 4708-4714
4. Lee SH, Kim WH, Kim HK, Woo KM, Nam HS, Kim HS, Kim JG, Cho MH. Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas. Biochem Biophys Res Commun 2001; 284 850-855
5. Ishii H, Ozawa K, Furukawa Y. Alteration of the fragile histidine triad gene early in carcinogenesis: an update. J Exp Ther Oncol 2003; 3: 291-296
6. Ishii H, Zanesi N, Vecchione A, Trapasso F, Yendamuri S, Sarti M, Baffa R, During MJ, Huebner K, Fong LY, Croce CM. Regression of upper gastric cancer in mice by FHIT gene delivery. FASEB J 2003; 17: 1768-1770
7. Siprashvili Z, Sozzi G, Barnes LD, McCue P, Robinson AK, Eryomin V, Sard L, Tagliabue E, Greco A, Fusetti L, Schwartz G, Pierotti MA, Croce CM, Huebner K. Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci USA 1997; 94: 13771-13776
8. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-1181
9. Pekarsky Y, Zanesi N, Palamarchuk A, Huebner K, Croce CM. FHIT: from gene discovery to cancer treatment and prevention. Lancet Oncol 2002; 3: 748-754
10. Zhao P, Song X, Nin YY, Lu YL, Li XH. Loss of fragile histidine triad protein in human hepatocellular carcinoma. World J Gastroenterol 2003; 9: 1216-1219
11. Michael D, Beer DG, Wilke CW, Miller DE, Glover TW. Frequent deletions of FHIT and FRA3B in barrett's metaplasia and esophageal adenocarcinomas. Oncogene 1997; 15: 1653-1659
12. Mori M, Mimori K, Shiraishi T, Alder H, Inoue H, Tanaka Y, Sugimachi K, Huebner K, Croce CM. Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus. Cancer Res 2000; 60: 1177-1182
13. Skopelitou AS, Mitselou A, Katsanos KH, Alexopoulou V, Tsianos EV. Immunohistochemical expression of Fhit protein in Helicobacter pylori related chronic gastritis, gastric precancerous lesions and gastric carcinoma: correlation with conventional clinicopathologic parameters. Eur J Gastroenterol Hepatol 2003; 15: 515-523
14. Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995; 19(Suppl 1): S37-S43
15. Lauwers GY. Defining the pathologic diagnosis of metaplasia, atrophy, dysplasia, and gastric adenocarcinoma. J Clin Gastroenterol 2003; 36(Suppl 5): S37-S43
16. Popiela T, Stachura J. Cancers of digestive tract. Gastroenterologia i Hepatologia Kliniczna, Konturek SJ. (Ed.), PZWL Warszawa 2001: 679-739
17. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997; 40: 297-301
18. Konturek PC, Konturek SJ, Starzyska T, Marlicz K, Bielanski W, Pierzchalski P, Karczewska E, Hartwich A, Rembiasz K, Lawniczak M, Ziemniak W, Hahn EC. Helicobacter pylori-gastrin link in MALT lymphoma. Aliment Pharmacol Ther 2000; 14: 1311-1318
19. Takeuchi K, Ohno Y, Tsuzuki Y, Ando T, Sekihara M, Hara T, Kuwano H. Helicobacter pylori infection and early gastric cancer. J Clin Gastroenterol 2003; 36: 321-324
20. Verkasalo PK, Kaprio J, Koskenvuo M, Pukkala E. Genetic predisposition, environment and cancer incidence: A nationwide twin study in Finland, 1976-1995. Int J Cancer 1999; 83: 743-749
21. Bakir T, Can G, Siviloglu C, Erkul S. Gastric cancer and other organ cancer history in the parents of patients with gastric cancer. Eur J Cancer Prev 2003; 12: 183-189
22. Khuri FR, Nemunaitis J, Ganly I, Arseneau J, Tannock IF, Romel L, Gore M, Ironside J, MacDougall RH, Heise C, Randlev B, Gillenwater AM, Bruso P, Kaye SB, Hong WK, Kirn DH. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat Med 2000; 6: 879-885
23. Ishii H, Dumon KR, Vecchione A, Trapasso F, Mimori K, Alder H, Mori M, Sozzi G, Baffa R, Huebner K, Croce CM. Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells. Cancer Res 2001; 61: 1578-1584